Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP)open access
- Kang, Jae Seung; Mok, Lydia; Heo, Jin Seok; Han, In Woong; Shin, Sang Hyun; Yoon, Yoo-Seok; Han, Ho-Seong; Hwang, Dae Wook; Lee, Jae Hoon; Lee, Woo Jung; Park, Sang Jae; Park, Joon Seong; Kim, Yonghoon; Lee, Huisong; Yu, Young-Dong; Yang, Jae Do; Lee, Seung Eun; Park, Il Young; Jeong, Chi-Young; Roh, Younghoon; Kim, Seong-Ryong; Moon, Ju Ik; Lee, Sang Kuon; Kim, Hee Joon; Lee, Seungyeoun; Kim, Hongbeom; Kwon, Wooil; Lim, Chang-Sup; Jang, Jin-Young; Park, Taesung
- Issue Date
- EDITORIAL OFFICE GUT & LIVER
- Pancreatic neoplasms; Survival; Prognosis
- GUT AND LIVER, v.15, no.6, pp.912 - 921
- Journal Title
- GUT AND LIVER
- Start Page
- End Page
- Background/Aims: Several prediction models for evaluating the prognosis of nonmetastatic resected pancreatic ductal adenocarcinoma (PDAC) have been developed, and their performances were reported to be superior to that of the 8th edition of the American Joint Committee on Cancer (AJCC) staging system. We developed a prediction model to evaluate the prognosis of resected PDAC and externally validated it with data from a nationwide Korean database. Methods: Data from the Surveillance, Epidemiology and End Results (SEER) database were utilized for model development, and data from the Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP) database were used for external validation. Potential candidate variables for model development were age, sex, histologic differentiation, tumor location, adjuvant chemotherapy, and the AJCC 8th staging system T and N stages. For external validation, the concordance index (C-index) and time-dependent area under the receiver operating characteristic curve (AUC) were evaluated. Results: Between 2004 and 2016, data from 9,624 patients were utilized for model development, and data from 3,282 patients were used for external validation. In the multivariate Cox proportional hazard model, age, sex, tumor location, T and N stages, histologic differentiation, and adjuvant chemotherapy were independent prognostic factors for resected PDAC. After an exhaustive search and 10-fold cross validation, the best model was finally developed, which included all prognostic variables. The C-index, 1-year, 2-year, 3-year, and 5-year time-dependent AUCs were 0.628, 0.650, 0.665, 0.675, and 0.686, respectively. Conclusions: The survival prediction model for resected PDAC could provide quantitative survival probabilities with reliable performance. External validation studies with other nationwide databases are needed to evaluate the performance of this model.
- Files in This Item
- There are no files associated with this item.
- Appears in
- College of Medicine > Department of Medicine > Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.